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Abstract
B-1 lymphocytes are the predominant cells in mouse peritoneal cavity. They express macrophage and lymphocyte markers
and are divided into B-1a, B-1b and B-1c subtypes. The role of B-1 cells is not completely clear, but they are responsible for
natural IgM production and seem to play a regulatory role. An enriched B-1b cell population can be obtained from non-
adherent peritoneal cell cultures, and we have previously demonstrated that these cells undergo differentiation to acquire a
mononuclear phagocyte phenotype upon attachment to the substrate in vitro. Nevertheless, the B-1 cell response to
antigens or adjuvants has been poorly investigated. Because killed Propionibacterium acnes exhibits immunomodulatory
effects on both macrophages and B-2 lymphocytes, we analyzed whether a killed bacterial suspension or its soluble
polysaccharide (PS) could modulate the absolute number of peritoneal B-1 cells in BALB/c mice, the activation status of
these cells and their ability to differentiate into phagocytes in vitro. In vivo, P. acnes treatment elevated the absolute number
of all B-1 subsets, whereas PS only increased B-1c. Moreover, the bacterium increased the number of B-1b cells that were
positive for MHC II, TLR2, TLR4, TLR9, IL-4, IL-5 and IL-12, in addition to up-regulating TLR9, CD80 and CD86 expression. PS
increased B-1b cell expression of TLR4, TLR9, CD40 and CD86, as well as IL-10 and IL-12 synthesis. Both of the treatments
decreased the absolute number of B-1b cells in vitro, suggesting their early differentiation into B-1 cell-derived phagocytes
(B-1CDP). We also observed a higher phagocytic activity from the phagocytes that were derived from B-1b cells after P.
acnes and PS treatment. The adjuvant effect that P. acnes has on B-1 cells, mainly the B-1b subtype, reinforces the
importance of B-1 cells in the innate and adaptive immune responses.
Citation: Mussalem JS, Squaiella-Baptista˜o CC, Teixeira D, Yendo TM, Thies FG, et al. (2012) Adjuvant Effect of Killed Propionibacterium acnes on Mouse Peritoneal
B-1 Lymphocytes and Their Early Phagocyte Differentiation. PLoS ONE 7(3): e33955. doi:10.1371/journal.pone.0033955
Editor: Holger Bruggemann, Aarhus University, Denmark
Received June 24, 2011; Accepted February 21, 2012; Published March 20, 2012
Copyright:  2012 Mussalem et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by Sao Paulo Research Foundation (FAPESP), National Counsel of Technological and Scientific Development (CNPq),
Coordination for the Improvement of Higher Education Brasil (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or
preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: imaugeri@unifesp.br
Introduction
B lymphocytes can be divided in B-2 cells, which are abundant
in the spleen, lymph nodes and peripheral blood of mice and
continuously arise from bone marrow precursors, and B-1 cells,
which arise from fetal and neonatal progenitors early in life [1],
are enriched in mouse peritoneal and pleural cavities and can be
distinguished by the expression of specific surface markers (CD5,
CD11b and CD43) [2].
Peritoneal B-1 cells are comprised of 3 subsets: B-1a (CD11b+
CD5+) cells, B-1b (CD11b+ CD52) cells and B-1c cells (CD11b2
CD5+) [2,3], with the last subset recently being described as a
precursor of the others [4].
The production of natural IgM antibodies [5] has been
described as a function of B-1 cells, and B-1b cells have been
found to have specific roles in autoimmunity [6], antigen tolerance
[7] and the increase in murine melanoma cell metastatic behavior
and malignancy [8,9]. In addition, Escherichia coli-derived LPS is
known to induce B-1 stimulation in vivo and in vitro [10,11], and the
antigen-presenting function of peritoneal cells stimulated with
CpG is mainly attributed to B-1b cells [12]. Our laboratory has
also demonstrated that a non-adherent B-1b cell enriched
population can be obtained after culturing peritoneal cells for 5
days [13] and that these cells become adherent and differentiate
into B-1 cell-derived phagocytes (B-1CDP) when they are re-
cultivated for more than 5 days [14].
Therefore, B-1 lymphocytes are involved in essential immune
mechanisms and can be important targets for immune modulation
by biological adjuvants. However, it is noteworthy that the B-1 cell
response to antigen or adjuvants is poorly understood. Our group
recently described how killed Propionibacterium acnes (P. acnes) and a
purified soluble polysaccharide (PS) extracted from the bacterial
wall increase the absolute number of peritoneal B-1a cells [15].
P. acnes, a Gram-positive bacillus, is the major constituent of the
normal human adult skin microflora [16]. In mice, killed P. acnes
induces biological effects that modulate the innate and acquired
immune responses, causing increased phagocytic [17,18] and
tumoricidal activities in macrophages [15,19,20], increased
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antibody responses [21,22] and increased resistance to different
pathogens [22–24].
Recently [18,25] we characterized a purified soluble polysac-
charide that can be extracted from the P. acnes cell wall (PS) with
phenol and is the bacterial component involved in several of the P.
acnes adjuvant effects. Similarly to the whole bacterium, PS
increased nitric oxide (NO) and TNF-a synthesis [18] and
tumoricidal and phagocytic activities in peritoneal macrophages
[15].
An important effect of P. acnes and PS is their capacity to direct
the immune response toward a Th1 or Th2 response, as
demonstrated in a murine model of immediate hypersensitivity
(Th2 response) to ovalbumin (OVA) [26]. In this model, a Th2
response was potentiated when P. acnes or PS were administered
simultaneously with OVA, but this result changed to a typical Th1
response when the mice were treated before OVA sensitization
[25,27].
We also found that killed P. acnes or PS exert a potent adjuvant
effect on Trypanosoma cruzi (T. cruzi) DNA immunization,
enhancing the T. cruzi-specific Th1 immune response and
significantly decreasing mouse parasitemia after challenge [22].
These results suggest that P. acnes and PS act directly on antigen-
presenting cells (APC), which is in agreement with the increased
number and activation status of bone marrow-derived dendritic
cells obtained from P. acnes- or PS-treated mice [28].
The mechanisms by which P. acnes acts on APCs seem to involve
toll-like receptors (TLRs). The P. acnes effects, including pro-
inflammatory cytokine synthesis [29], were shown to be related to
TLR2 and TLR9 activation [30,31]. Jugeau et al. [32] also
demonstrated that P. acnes induces TLR2 and TLR4 expression on
keratinocytes. In addition to the TLRs, the bacterium can also
modulate co-stimulatory and MHC II molecules in vivo [28].
These data indicate that P. acnes preferentially acts on innate
immune cells; primarily macrophages and dendritic cells. In fact,
most P. acnes effects, such as pathogen resistance and phagocytic
and tumoricidal activities, are related to the modulation of
macrophages, usually those obtained from the peritoneal cavity.
Thus, considering the fact that B-1 cells participate in the innate
and adaptive immune responses and P. acnes is a powerful
adjuvant, we investigated the modulatory effects that P. acnes and
the PS compound exert on peritoneal B-1 cells.
Materials and Methods
Animals
Six to eight week-old female or male BALB/c mice were used in
all of the experiments.
Ethics statement
All of the experiments were conducted with institutional animal
care. This study was approved by the University Ethics Committee
(ID number: 1210/2004).
Antigens
Heat-killed P. acnes suspension. The bacteria (obtained
from Instituto Adolfo Lutz, Sa˜o Paulo, S.P., Brazil) were cultured
in anaerobic medium (Hemobac, Probac, Sa˜o Paulo, S.P., Brazil)
for 3 days at 37uC and washed by centrifugation. The pellet was
re-suspended in 0.9% saline and subjected to continuous water
vapor for 20 min at 120uC. The protein concentration of the
suspension was determined by the Bradford method [33].
Purified soluble polysaccharide (PS). The polysaccharide
extraction and purification were performed as previously
described [18,25]. Briefly, 30 ml of heat-killed P. acnes (800 mg of
protein/ml) were mixed with 30 ml of 90% phenol and 30 ml of
distilled water and incubated for 10 min in a 70uC water bath, as
described by the Palmer and Gerlough [34] protocol for
polysaccharide extraction. After centrifugation at 2,0006 g and
4uC, the water phase and the polysaccharide-enriched ring were
collected. This step was repeated 3 times. Three volumes of
ethanol were added to each volume of the mixture. After an
overnight incubation at 4uC, the precipitate was obtained by
centrifugation and designated as the soluble polysaccharide (PS).
The carbohydrate concentration was determined by the Dubois
method [35].
Treatment protocol
The mice received a single intraperitoneal (ip) injection of either
140 mg heat-killed P. acnes (n = 20) or 25 mg PS (n= 20) in a 350 ml
injection. The control group (n= 30) consisted of mice that were
treated with sterile 0.9% saline under the same conditions. After
24 h, the peritoneal exudate cells (PEC) were collected and
analyzed by flow cytometry (in vivo) or subjected to a B-1b enriched
culture protocol for 5 days (in vitro).
B-1b cell enriched culture
The B-1b lymphocytes were cultured using the protocol
described by Almeida et al. [13]. The cells were obtained by
washing the abdominal cavities (peritoneal exudate) of the mice
with RPMI (Sigma, St. Louis, MO, USA). Then, 46106 cells/
15 ml were cultured for 1 h at 37uC in a 5% CO2 atmosphere.
After this time, the non-adherent cells were discarded. The
adherent cells remained in the culture bottle, to which 15 ml of
RPMI containing 10% heat-inactivated fetal bovine serum (R10)
were added. The cells were incubated in the same conditions for 5
days without changing the culture medium. After this period, the
non-adherent cells were collected and analyzed by flow cytometry.
It is important to note that this culture provides a B-1b enriched
population, which means that, although B-1b lymphocytes are the
major subset, other cell types can also be present. For this reason,
we not only analyzed the number and activation status of the B-1b
cells in these cultures but also the number and status of the B-1a
and B-1c cells.
Absolute number of B-1 cells
The cell suspensions obtained from the PEC or the cultures
were both counted with Trypan Blue to determine the cellular
viability and concentration (total absolute number of cells/ml).
The cells were incubated with 5% normal mouse serum for
30 min at 4uC to block Fc receptors. The cells were washed and
stained with FITC-conjugated anti-mouse CD23, PE-conjugated
anti-mouse CD19, PerCP-conjugated anti-mouse CD5 and APC-
conjugated anti-mouse CD11b (Pharmingen, San Diego, CA,
USA) for 1 h at 4uC. All of the samples were fixed with 1%
paraformaldehyde for 30 min at 4uC. The stained cells were
evaluated using a FACSCalibur flow cytometer (Becton Dickinson,
San Jose, CA, USA), and the B-1a, B-1b and B-1c populations
were analyzed by CellQuest Pro software (Becton Dickinson, San
Jose, CA, USA).
The B-1a and B-1b lymphocyte analyses were performed
concomitantly in two gates. The first gate contained small cells
corresponding to lymphocytes, whereas the second gate contained
larger, more granular cells that generally correspond to macro-
phages. We evaluated the B-1 lymphocytes in the second gate
because it has been recently demonstrated that B-1 cells, which
also express CD11b+, form tightly associated doublets that are
often present in the macrophage gate [4]. We considered the
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absolute numbers of B-1a and B-1b cells to be the sum of the
values obtained in both gates.
The percentages were obtained based on 10,000 events. The
absolute cell number for each treated group was calculated from
the mean of the total cell number contained in 1 ml of PEC per
mouse or the mean of the total cell number contained in 1 ml of
culture.
Co-stimulatory and MHC II molecule expression
The cells obtained from the PEC or the B-1b enriched cultures
were analyzed for co-stimulatory and MHC II molecule
expression by flow cytometry. To verify the expression of co-
stimulatory and MHC II molecules in the lymphocyte population,
the cells were stained with biotin-conjugated anti-mouse CD40,
CD80 or CD86 followed by FITC-conjugated streptavidin or
FITC-conjugated anti-mouse I-Ad (MHC II), PE-conjugated anti-
mouse CD19, PerCP-conjugated anti-mouse CD5 and APC-
conjugated anti-mouse CD11b (PharMingen). The cell percent-
ages and mean fluorescence intensity (MFI) were obtained. The
absolute cell number in each treatment group was calculated as
described above.
Extracellular TLR expression
The expression of TLR2, TLR4 and extracellular TLR9 was
also analyzed in the cells from the PEC or cultures by flow
cytometry. TLR9 is located in an intracellular compartment, but
was recently shown to be expressed on the cell membrane of
human peripheral blood B lymphocytes [36].
To verify TLR2 and TLR4 expression in the lymphocyte
population, the cells were stained with purified rat anti-mouse
TLR2 or TLR4 (R&D Systems, Minneapolis, MN, USA) followed
by a FITC-conjugated anti-rat antibody, PE-conjugated anti-
mouse CD19, PerCP-conjugated anti-mouse CD5 and APC-
conjugated anti-mouse CD11b (PharMingen). To determine
TLR9 expression, the lymphocytes were incubated with purified
rabbit anti-mouse TLR9 (Zymed, San Francisco, CA, USA)
followed by a PerCP-conjugated anti-rabbit antibody, FITC-
conjugated anti-mouse CD5, PE-conjugated anti-mouse CD19
and APC-conjugated anti-mouse CD11b. The stained cells were
analyzed, and the cell percentages and mean fluorescence intensity
(MFI) were obtained. The absolute cell number was determined as
described above.
Intracellular TLR9 expression and cytokine synthesis
The cells obtained from the PEC or culture were stained as
described above to determine the B-1 subsets. The cells were then
fixed with 1% paraformaldehyde for 15 min at 4uC and
permeabilized with 200 ml of 0.2% Triton-X-100 for 6 min at
room temperature in the dark. The cells were washed and stained
with anti-TLR9 as described above. For cytokine detection, the B-
1 lymphocyte subsets were labeled with PE-conjugated anti-mouse
IL-4, PE-conjugated anti-mouse IL-5, FITC-conjugated anti-
mouse IL-10 or PE-conjugated anti-mouse IL-12 (Pharmingen).
The stained cells were analyzed by flow cytometry, and the cell
percentages and mean fluorescence intensity (MFI) were obtained.
The absolute cell number in each treatment group was calculated
as described above.
B-1b cell-derived phagocytes (B-1CDP)
The B-1b cells were obtained from the different treatment
groups using the protocol described in Almeida et al. [13]. After 5
days in culture, the supernatant containing the non-adherent cells
was harvested, centrifuged and re-cultured in R10 medium.
For the microscopic analysis, 2.56105 cells/ml (1 ml) were
dispensed onto cover glasses inserted into 24-well tissue culture
plates. These cells were re-cultured for 1, 9, 24 and 120 hours.
The cover glasses were washed twice with PBS, and the adherent
cells were fixed with 0.5% glutaraldehyde, stained with Giemsa,
and analyzed by optical microscopy. For the RNA extraction
procedure, 16106 cells were re-cultured in plastic dishes and
maintained in culture for 5 days.
Reverse transcriptase-polymerase chain reaction (RT-PCR)
analysis for hematopoietic transcription factors
Total RNA was extracted from the cells in each treatment
group before and after re-culturing for differentiation into
phagocytes using the TRIzol protocol specified by the manufac-
turer (Invitrogen, Carlsbad, CA, USA). The first-strand cDNA was
synthesized with Super-Script III RNase H reverse transcriptase
using an oligo (dT) primer (Invitrogen).
The reagents and thermocycling profiles that were used have
previously been described by Popi et al. [14]. Briefly, the
concentration of cDNA in the different samples was calibrated
using GAPDH cDNA. The PCR protocol consisted of a
denaturing step at 94uC for 2 min, 30 cycles of denaturing at
94uC for 30 sec, annealing at the primer-specific temperature for
30 sec, and primer extension at 72uC for 30 sec, and a final
extension at 72uC for 10 min. The PCR products were resolved
on agarose gels and visualized by ethidium bromide staining. The
images were captured and quantified using a Kodak Digital
Science Electrophoresis Documentation and Analysis System 120
(Eastman Kodak Co., Rochester, NY, USA).
B-1CDP phagocytic function
The B-1b cells were re-cultured in 24-well culture plates
containing a cover glass in each well at a concentration of 2.56105
cells/ml. After 24 or 120 hours, the non-adherent cells were
discarded and a Saccharomyces cerevisiae cell suspension was added to
the adherent population at a concentration of 5 yeasts per cell
(determined on the basis of the number of B-1b cells at the
beginning of the experiment (1.256106 yeasts/ml), and incubated
for 1 h. The cover glasses were washed 3 times with PBS, fixed
with 0.5% glutaraldehyde and stained with Giemsa. Phagocytosis
was quantified with oil-immersion microscopy (10006). Two
hundred cells were evaluated by counting the number of
internalized yeast cells. The endocytic index (EI) was determined
using the following relationship: EI = (percentage of cells contain-
ing at least one yeast cell)6(average number of yeast cells per
phagocytic cell).
Statistical analysis
Student’s t-test was used to determine significant differences
between the control group and each treatment group, and p values
smaller than 0.05 (p,0.05) were considered significant.
Results
P. acnes increases the absolute number of mouse
peritoneal B-1 cells
We first analyzed the B-1 cell subtypes obtained from the
peritoneal cavity of BALB/c mice treated with saline (control
group – Fig. 1 A), P. acnes (Fig. 1 B) or PS (Fig. 1 C). We analyzed
the cells located in the R1 (small cells) and R2 (large granular cells)
gates separately. All of the B-1 cells in both gates were CD19+
CD232 (R3 and R4) (Fig. 1 A to C). Within the CD19+ CD232
cell population, the B-1b subtype was characterized by a CD11b+
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CD52 phenotype (upper left quadrant in the R3 and R4 dot plots),
whereas the B-1a cells were CD11b+ CD5+ (upper right quadrant
in the R3 and R4 dot plots) and the B-1c cells were CD5+
CD11b2 (lower right quadrant in the R3 dot plot) (Fig. 1 A to C).
We decided to include the data for the B-1a and B-1c cells in our
statistical analysis (despite their low numbers) because the P. acnes
and PS treatments exerted interesting effects on these small
populations and their activation status, as described below.
Considering the sum of both the R1 (small cells) and R2
(doublets, large cells) gates, P. acnes treatment significantly
enhanced (p,0.05) the absolute number of B-1b cells in vivo
compared with the control group (Fig. 1 D). There was also a
significant increase (p,0.05) in the absolute numbers of B-1a and
B-1c cells in the P. acnes-treated mice compared with the control
group, but these numbers remained lower than the absolute
number of B-1b cells (Fig. 1 D).
In contrast to treatment with P. acnes, PS treatment decreased
the absolute number of B-1b cells compared with the control
treatment (Fig. 1 D), but significantly increased (p,0.05) the
absolute number of B-1c cells compared with the saline- or P.
acnes-treatments (Fig. 1 D).
Impairment of B-1 subsets in a B-1b enriched cell culture
from P. acnes- and PS-treated mice
The B-1b enriched cell cultures were analyzed by flow
cytometry as described above (Fig. 1 A to C). All three B-1
subtypes were detected in the supernatant obtained from the 5th
day of in vitro culture, although B-1b remained the major
population in all of the treatment groups (Fig. 1 E). The absolute
number of B-1b cells was higher in the control group in vitro than in
vivo (Fig. 1 E). This result was expected, because the enrichment of
B-1b cells in culture has already been demonstrated [13]. The P.
acnes and PS treatments significantly decreased (p,0.05) the
absolute number of B-1b and B-1a cells present in the in vitro
cultures compared with the control group (Fig. 1 E).
The absolute number of B-1c cells did not differ significantly
between the P. acnes and control cultures. In contrast, the PS
treatment significantly decreased (p,0.05) the absolute number of
these lymphocytes compared with the saline and P. acnes
treatments (Fig. 1 E).
P. acnes and PS activated B-1 cell subsets, modulating
cell surface molecule expression and cytokine synthesis
in vivo
To analyze the molecular effects that P. acnes and PS have on
peritoneal B-1 cell activation, we studied the expression of the
TLRs, MHC II, CD40, CD80, CD86 and cytokines by these cells
24 h after treatment. Undoubtedly, the bacterium and the
polysaccharide compound influenced the activation of the B-1b
cells more than the other subsets, perhaps because this was the
major B-1 subset in the mouse peritoneal cavity.
P. acnes significantly increased the absolute number of B-1b cells
expressing all of the toll-like receptors studied here (TLR2, TLR4,
intra- and extracellular TLR9) and the absolute number of B-1b
cells expressing MHC II and co-stimulatory molecules (Fig. 2 A
and B). In contrast, PS decreased the absolute number of these
cells compared to the saline and P. acnes treatments (Fig. 2 A and
B). The bacterium also increased the absolute number of B-1b cells
synthesizing IL-4, IL-5 and IL-12, whereas PS reduced the
number of cells positive for IL-10 and IL-12 (Fig. 2 C).
When we determined the expression intensity (MFI) of these cell
surface molecules, we observed that the P. acnes treatment caused
the B-1b lymphocytes to significantly up-regulate their expression
of extracellular TLR9, CD80 and CD86 relative to the control
group and that PS caused these cells to up-regulate TLR4 and
extracellular TLR9, as well as CD40 and CD86 (Fig. 2 D and E).
P. acnes decreased the level of IL-10 produced by these cells, but PS
significantly increased IL-10 and IL-12 synthesis (Fig. 2 F).
Similar to the results observed in the B-1b lymphocytes, P. acnes
also increased the absolute number of B-1a cells that were positive
for all of the TLRs, activation molecules and cytokines studied. PS
diminished the absolute number of these cells compared with the
control and P. acnes treatments (Fig. S1 A to C). The extracellular
TLR9 levels, CD80 expression and IL-5 production were also up-
regulated in the P. acnes group, and TLR2, TLR4, extracellular
TLR9, CD86 and IL-12 were up-regulated in the B-1a cells from
the PS-treated mice (Fig. S1 D to F).
In contrast, the P. acnes and PS effects on the B-1c cell
activation molecules were slightly different from the effects these
treatments exerted on the B-1b and B-1a cells, with the B-1c cells
exhibiting an increase in the number of cells positive for TLR2,
TLR4 and MHC II, but a decrease in the absolute number of
cells expressing extracellular TLR9, CD40, CD80 and CD86
(Fig. S2 A and B). In addition, the P. acnes treatment also elevated
the number of these cells synthesizing IL-4 and IL-5, whereas PS
increased the number of IL-4, IL-10 and IL-12 positive cells (Fig.
S2 C). Interestingly, P. acnes did not modulate the expression of
any activation molecule on the B-1c lymphocytes, but increased
the production of IL-5 and IL-12, whereas PS only up-regulated
TLR4, extracellular TLR9, CD40 and CD86 expression (Fig. S2
D to F).
B-1 cells from the P. acnes- and PS-treated mice remained
activated in B-1b enriched cultures, despite a decrease in
absolute number
Because the P. acnes and PS treatments modulated the levels of
all the B-1 lymphocytes in vivo, and considering that all three
subsets were detected in the B-1b enriched cultures, we decided to
evaluate how these lymphocytes could be modulated by P. acnes
and PS in vitro.
As described above, in vivo treatment with P. acnes or PS
decreased the absolute number of B-1b and B-1a cells in the
supernatant obtained from the 5th day of culture. Consequently,
the absolute number of B-1b and B-1a cells staining positively for
the TLRs, MHC II, co-stimulatory molecules and cytokines in vitro
also decreased in the P. acnes and PS groups compared with the
control group (Fig. 3 and S3 A to C). The B-1c lymphocytes were
an exception in this case because, although the absolute number of
these cells decreased (mainly in the PS group), the number of cells
positive for TLR2, extracellular TLR9 and MHC II increased in
Figure 1. Determination of the absolute number of B-1 cell subsets in vivo and in vitro. Peritoneal cells from P. acnes-, PS- or saline-treated
mice were analyzed 24 h after treatment (in vivo). The non-adherent population of 5-day-old B-1b enriched cultures was also analyzed (in vitro). The
cells were stained with mAbs to identify the B-1 cell subsets. (A to C) The small (R1) and large granular (R2) cells from the SSC-H6FSC-H dot plots are
shown, followed by the CD236CD19 analysis from R1 and R2 and the CD56CD11b analysis from R3 and R4. (D and E) The absolute numbers of B-1b,
B-1a and B-1c lymphocytes from mice treated with saline (control group), P. acnes and PS. The absolute numbers of the B-1a and B-1b lymphocytes
are the sum of R1 and R2, and the B-1c values are derived from R1. The absolute cell number is the mean of two independent experiments with
similar results. * p,0.05 compared to the control group. # p,0.05 between the P. acnes and PS treated groups.
doi:10.1371/journal.pone.0033955.g001
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both treatment groups, as did the levels of IL-10 and IL-12 in the
P. acnes group (Fig. S4 A to C).
Despite their lower cell numbers, the B-1b lymphocytes
obtained from the P. acnes and PS peritoneal cell cultures
remained more activated than the cells from the control group,
as evidenced by higher TLR4, CD40 and CD80 expression in
both treatment groups, higher TLR2 expression in the P. acnes
group and higher IL-4 synthesis in the PS group (Fig. 3 D to F).
The B-1a cells from the treated groups also maintained their
activation status in vitro despite their lower absolute number, as
demonstrated by the up-regulation of extracellular TLR9 and
CD80 in the P. acnes culture and the up-regulation of TLR2,
TLR4 and extracellular TLR9 in the PS culture (Fig. S3 D and E).
None of the treatments increased the cytokine synthesis by the B-
1a lymphocytes in vitro (Fig. S3 F).
Finally, the B-1c lymphocytes from the P. acnes and PS cell cultures
also remained more activated than the B-1c cells in the control
culture, as evidenced by the up-regulation of extra- and intracellular
TLR9, MHC II expression and IL-10 synthesis in the P. acnes
treatment and the up-regulation of TLR2, extra- and intracellular
TLR9, MHC II and IL-4 in the PS treatment (Fig. S4 D to F).
Although all of the B-1 subsets were detected in the
supernatants from the 5th day of culture and were activated by
the P. acnes and PS treatments, it is unquestionable that the B-1b
Figure 2. Analysis of the activation status of B-1b lymphocytes in vivo. Cells from P. acnes-, PS- or saline- (control group) treated mice were
analyzed 24 h after treatment to determine TLR, co-stimulatory molecule, MHC II and cytokine expression by B-1b lymphocytes. The cells were
stained with mAbs to determine the absolute number (A to C) of B-1b lymphocytes that expressed each molecule and the mean fluorescence
intensity (MFI) of each marker (D to F). The absolute cell number and MFI are the means of two independent experiments with similar results.*
p,0.05 between the control and treated groups. #p,0.05 between the P. acnes and PS treated groups.
doi:10.1371/journal.pone.0033955.g002
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lymphocytes were the major population in these cultures and that
P. acnes and PS exerted stronger effects on this subset. In addition,
because this subpopulation has been shown to differentiate into
phagocytes in vitro, we decided to investigate the effects that P. acnes
and PS specifically have on the differentiation process.
P. acnes induced the early in vitro differentiation of B-1b
cells into phagocytes
As described above, when the non-adherent B-1b lymphocytes
obtained from the 5 day old peritoneal cell culture are re-cultivated
for an additional 5–10 days, they become adherent and differentiate
into phagocytes [14]. The B-1b cells that were obtained from the
saline-, P. acnes- or PS-treated groups of this study were re-cultivated
for different periods (1 to 120 hours), and the phagocyte
differentiation was analyzed by adherence and morphology.
We observed that the B-1b cells obtained from the P. acnes group
differentiated into mononuclear phagocytes earlier, as there were
more adherent lymphocytes in these cultures within the first hour
and the cells were more spread out than those in the PS and
control groups (Fig. 4).
Figure 3. Analysis of the activation status of B-1b lymphocytes in vitro. The non-adherent cell population that was obtained after 5 days in a
B-1b enriched culture obtained from P. acnes-, PS-, or saline- (control group) treated mice was analyzed to determine TLR, co-stimulatory molecule,
MHC II and cytokine expression in B-1b lymphocytes. The cells were stained with mAbs to identify the absolute numbers (A to C) of B-1b lymphocytes
that expressed each molecule and the mean fluorescence intensity (MFI) of each marker (D to F). The absolute cell number and MFI are the means of
two independent experiments with similar results. * p,0.05 between the control and treated groups. # p,0.05 between the P. acnes and PS treated
groups.
doi:10.1371/journal.pone.0033955.g003
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There was an increase in the number of adherent cells in all
three groups during the culture period, and these cells became
large and projected pseudopods from two opposite cellular poles.
These pseudopods became more prominent in the cells from the P.
acnes group, and typical bipolar cells appeared within 9 to 24 hours
(Fig. 4).
Although all three groups contained cells that were adherent
and spread out at the end of re-culture period (120 hours), there
were many more B-1 cell-derived phagocytes in the P. acnes
cultures, whose cover glasses were almost completely filled (Fig. 4).
The P. acnes and PS treatments induced the early
myeloid commitment of B-1 cells, decreasing the
expression of lymphoid genes
The expression of lymphoid and myeloid genes was analyzed in
B-1 cells obtained from the B-1b enriched population (before re-
culture) and the B-1CDP cultures (after re-culture) (Fig. 5).
The cells from the B-1b enriched populations (before re-culture)
that were obtained from the P. acnes and PS groups expressed
lower levels of lymphoid genes such as CD19, VpreB and EBF (P.
acnes group) and E2A (PS group) compared with the control group
(Fig. 5). It is important to note that while the P. acnes and PS
treatments decreased lymphoid gene expression in the B-1 cells,
they sustained or increased the expression of myeloid genes such as
lysozyme (Lys), M-CSFR, F4/80, PU.1 and G-CSFR (Fig. 5),
indicating the early myeloid commitment of the B-1 cells from
these groups.
When the B-1 lymphocytes were subjected to in vitro phagocyte
differentiation (after re-culture), virtually all of the lymphoid genes
were down-regulated in the cells from all three groups (Fig. 5). The
expression of some myeloid factors also decreased after phagocyte
differentiation, but genes such as F4/80 and PU.1, M-CSFR
(saline group), G-CSFR (P. acnes group) and lysozyme (PS-treated
group) remained sustained or increased (Fig. 5). The P. acnes and
PS treatments clearly enhanced the myeloid commitment of the B-
1CDP cells, as the down-regulation of some lymphoid genes was
more pronounced in the treated groups after re-culture, with lower
Figure 4. Differentiation of B-1b cells into B-1 cell-derived
phagocytes (B-1CDP). The peritoneal cells from mice treated with P.
acnes, PS or saline (control group) were cultured for 5 days. The non-
adherent cells were re-cultured on cover glasses for 1 to 120 hours for
phagocyte differentiation. The cells that adhered to the cover glasses
were then fixed, stained with Giemsa and analyzed using optical
microscopy. Magnification 5006.
doi:10.1371/journal.pone.0033955.g004
Figure 5. Myeloid and lymphoid gene expression by B-1b-
enriched cells and B-1 cell-derived mononuclear phagocytes
(B-1CDP). The peritoneal cells from P. acnes-, PS- or saline-treated mice
were cultured for 5 days. The non-adherent population (B-1b-enriched
cells) was re-cultured for 5 more days for phagocyte differentiation (B-
1CDP). After each of these periods, the lymphoid and myeloid gene
expression by B-1b cells (before re-culture) and B-1CDP (after re-culture)
was analyzed by reverse transcriptase-polymerase chain reaction (RT-
PCR). The PCR products were amplified using primers that detected the
indicated transcripts. The PCR products were visualized on agarose gels
by ethidium bromide staining. The amount of input cDNA was
normalized by analyzing the control GAPDH transcripts. IL-7Ra: alpha
subunit for interleukin 7 receptor, E2A: E box protein, Pax5: paired box
5, VpreB: surrogate light chain, EBF: early B-cell factor, LYS: Lysozyme;
M-CSFR: macrophage colony-stimulating factor receptor, G-CSFR:
granulocyte colony-stimulating factor receptor, GAPDH: glyceraldehyde
3-phosphate dehydrogenase.
doi:10.1371/journal.pone.0033955.g005
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levels of Pax 5, EBF and CD19 in the P. acnes cultures and lower
E2A, VpreB and CD19 levels in the PS cultures compared with
the control cultures (Fig. 5). P. acnes also increased the expression of
M-CSFR and G-CSFR in the B-1CDP cells relative to the control
group (Fig. 5), further suggesting the enhanced myeloid commit-
ment of these cells.
P. acnes soluble polysaccharide increased the percentage
of B-1CDP cells exhibiting phagocytic activity after
120 hours of re-culture
The B-1b enriched cells from the supernatant obtained on the
5th day of culture were re-cultured for 24 or 120 hours to
differentiate into phagocytes (B-1CDP). After each time period,
Saccharomyces cerevisiae yeast cells were added to the cultures, and the
phagocytic function of the cells was determined by calculating the
phagocytic index.
We did not observe significant differences in the phagocytic
indices of the B-1CDP cells from the different groups at 24 or
120 hours after re-culture, but there was a tendency for the
phagocytic index to be higher at 120 hours than 24 hours in all
three groups (Fig. 6). There was no significant difference in the
number of phagocytic cells obtained within 24 hours between the
treated and control groups; however, the percentage of B-1CDP
cells exhibiting phagocytic activity at 120 hours was significantly
higher in the PS group than the control group (Fig. 6). Therefore,
although in vivo P. acnes treatment enhanced the differentiation of
B-1CDP cells in vitro, it did not enhance the cells’ phagocytic
function. Only the PS compound increased the number of B-
1CDP cells exhibiting phagocytic activity.
Discussion
In the present study, we demonstrated that P. acnes exerts an
adjuvant effect on B-1 lymphocytes obtained from mouse
peritoneal exudate cells. We also demonstrated that the soluble
polysaccharide (PS) extracted from the bacterial wall is the
compound responsible for some of the effects of the killed P. acnes
suspension.
The levels of all B-1 subsets were elevated in the peritoneal
exudate after P. acnes treatment; however, the B-1b cells remained
the major subset. The adjuvant effect on absolute cell number
could be related to three conditions: (1) proliferation, (2)
differentiation and (3) cellular migration, all of which involve cell
activation. Undoubtedly, both PS and P. acnes were able to activate
B-1 cells in vivo by inducing changes in the expression of surface
molecules and cytokine synthesis.
The increase in the absolute number of cells expressing TLR2,
TLR4, and intra- and extracellular TLR9 was more pronounced
in the B-1b cells than the other subsets and may reflect their
proliferation and/or differentiation. P. acnes is a Gram-positive
bacillus that preferentially binds to the cell surface through TLR2
[30]. This property is responsible for the majority of its adjuvant
effects. The bacteria in the present study could have bound to B-1c
cells, which have been described as a precursor of B-1 lymphocytes
[4], and induced both cell proliferation and differentiation into B-
1a and B-1b cells, which could explain the increase in the absolute
number of all subsets (Fig. 1).
It also seems clear that the soluble polysaccharide extracted
from the bacterial wall is the component responsible for increasing
the number of B-1c cells because PS treatment only increased the
absolute number of B-1c cells (Fig. 1), including those expressing
TLR2 and TLR4 (Fig. S2 A). This effect could be due to the
precursor nature of this subset, which would allow them to
respond to a thymus-independent antigen [36] (such as PS) better
than to the whole bacteria. P. acnes and PS have already been
demonstrated to have effects on precursor cells that include
increasing the absolute number of CD34+ bone marrow
hematopoietic stem cells [28].
We also observed that P. acnes treatment differentially
modulated TLR expression on the surface of B-1 lymphocytes,
as determined by MFI. The whole bacterium only increased the
extracellular TLR9 level. It has recently been shown that TLR9 is
expressed on the cell membrane of human peripheral blood B
Figure 6. Evaluation of B-1CDP cell phagocytic activity. B-1b cells from the supernatant of 5 day-old cultures from the saline (control group),
P. acnes and PS groups were re-cultured for 24 or 120 hours to differentiate into phagocytes (B-1CDP). Saccharomyces cerevisiae cells were added to
the B-1CDP cells after each time point, and the phagocytic function was determined from the phagocytic index (bars) and the percentage of
phagocytic cells (lines). * p,0.05 between the control and PS groups at 120 hours (percentage of phagocytic cells).
doi:10.1371/journal.pone.0033955.g006
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lymphocytes [37]. Here, we are the first to demonstrate that B-1
lymphocytes from the mouse peritoneal cavity can also express
extracellular TLR9 and that P. acnes modulates extracellular TLR9
expression. Despite failing to elevate the absolute number of B-1b
cells expressing TLRs, PS did promote the higher expression of all
TLRmolecules (except intracellular TLR9) by this subtype (Fig. 2 D).
The polysaccharide-mediated interaction between bacteria and
TLR2 could trigger other signals that result in differential TLR
expression. In previous studies, TLR4 expression increased on
hepatocytes from mice that were intravenously treated with P. acnes
and challenged with LPS, demonstrating that the mechanism by
which bacteria enhance endotoxic shock [38] is mediated by the
up-regulation of TLR4 mRNA, which consequently enhances
TLR4 expression on the cell surface [39]. An increase in the
expression of both TLR2 and TLR4 was also demonstrated in
keratinocytes and associated with the initial inflammatory process
observed in acne lesions [32].
The bacterial-meditated up- or down-regulation of TLR
expression could be directly related to B-1 lymphocyte traffic.
Ha et al. [40] observed that peritoneal B-1 cell migration was
regulated by TLR signals that induce the specific, rapid and
transient down-regulation of integrins and CD9 on these cells,
promoting their detachment from the local matrix and movement
in response to chemokines. P. acnes-induced cell migration has
recently been analyzed by our group. We observed higher
numbers of dendritic cells, macrophages and NKT cells in the
peritoneal cavity [15,41]. Zhang et al. [42] demonstrated that
bacterial treatment increased the synthesis of MIP-1a, a
chemokine involved in monocyte and NKT recruitment, by
rabbit macrophages.
TLR modulation by P. acnes could directly interfere with MHC
II and co-stimulatory molecule expression and cytokine produc-
tion by B-1 lymphocytes, especially the B-1b subtype. The number
of B-1b cells expressing CD40, CD80, CD86, and MHC II and
producing IL-4 and IL-12 increased after P. acnes treatment. This
treatment also elevated CD80 and CD86 expression on the B-1b
membrane. These results clearly show that the adjuvant effect of P.
acnes influences B-1 cell antigen-presenting function. B-1b
lymphocytes obtained from adherent peritoneal cell cultures have
been demonstrated to be better antigen-presenting cells (APC)
than macrophages in vitro [12]. B-1b cells have recently been
shown to present internalized antigen to CD4+ T lymphocytes
[43].
In contrast, several studies have described the adjuvant effect
that P. acnes has on antigen-presenting cells such as dendritic cells,
macrophages and B-2 lymphocytes [22,28,44,45]. We observed a
direct bacterial effect on APCs in a murine asthma model, with the
Th2 response to OVA being potentiated or modulated depending
on the P. acnes treatment protocol [25,27].
The bacterial and PS-mediated modulation of B-1 lymphocytes
in vivo led us to investigate how these cells would behave in the B-
1b enriched culture that was described by Almeida et al. [13]. In
these cultures, B-1b cells can be obtained from the supernatant of
5 day old adherent peritoneal cell cultures.
P. acnes and PS diminished the number of B-1b cells in the
supernatant; however, these cells remained more activated than
the cells from the saline-enriched cultures. After the B-1b
lymphocytes obtained from the B-1b enriched cultures are re-
cultured for 120 hours, a large proportion of them are found to be
firmly adhered to the cover glass [13,14]. These adherent cells
spread to transform into B-1b cell-derived phagocytes (B-1CDP),
which have a morphology that is similar to macrophages. We also
demonstrated that B-1CDP cells express myeloid genes and silence
some lymphoid genes at this stage [14].
In the present work, we observed that P. acnes transformed B-1b
into B-1CDP cells at an early time point. When the B-1b enriched
cultures from P. acnes-treated mice were re-cultured, they
presented the characteristics of phagocytes within the first hour,
as evidenced by the large number of adherent and spread cells
with a bipolar shape (Fig. 4). Conversely, the cells in the other
groups were small and round at the same time point (Fig. 4). P.
acnes seems to anticipate the activation of intracellular pathways,
silencing lymphoid genes and resulting in the characteristics
observed in the B-1CDP cells.
Because Popi et al. [14] showed a relevant decrease in the
expression of lymphoid genes after B-1b re-culturing, we analyzed
the expression of lymphoid and myeloid genes in the B-1b and B-
1CDP populations obtained from the P. acnes- and PS-treated
groups.
In vivo treatment with P. acnes or PS silenced the lymphoid gene
program in B-1CDP cells. The E2A and EBF transcription factors,
which are involved in the early stages of B cell commitment, and
Pax-5, which is a gene induced by E2A and EBF, were particularly
affected. This finding clearly indicates that P. acnes or PS treatment
induces myeloid commitment in B-1 cells and supports their
differentiation into phagocytes after the lymphoid program is
silenced and myeloid gene transcription is activated.
Almeida et al. [13] have already demonstrated the phagocytic
activity of B-1b and B-1CDP cells in vitro. Thus, we evaluated
whether P. acnes and PS could enhance such phenomena. We
analyzed B-1CDP phagocytic function 24 and 120 hours after re-
culture. Although the bacterium anticipated phagocyte differen-
tiation, it did not potentiate the phagocytic function of the B-
1CDP cells. It seems that the bacterium can influence the early
differentiation of B-1b cells into phagocytes and enhance their
APC characteristics.
In this study we have demonstrated that P. acnes treatment in vivo
elevated the absolute number of B-1 cells and increased the
expression of the TLRs, MHC II and co-stimulatory molecules, all
of which are involved in capturing and processing antigens. These
effects remained when the cells were cultured in vitro.
The adjuvant effect that P. acnes exerts on B-1 cell subtypes
underscores the importance of B-1 cells in the early stages of the
immune response.
Supporting Information
Figure S1 Analysis of the activation status of B-1a
lymphocytes in vivo. Cells from the P. acnes-, PS- or saline-
(control group) treated mice were analyzed 24 h after treatment to
determine TLR, co-stimulatory molecule, MHC II and cytokine
expression by B-1a lymphocytes. The cells were stained with mAbs
to determine the absolute number (A to C) of B-1a lymphocytes
that expressed the studied molecules and the mean fluorescence
intensity (MFI) of each marker (D to F). The absolute cell number
and MFI are the means of two independent experiments with
similar results.* p,0.05 between the control and treated groups.
#p,0.05 between the P. acnes and PS treated groups.
(TIF)
Figure S2 Analysis of the activation status of B-1c
lymphocytes in vivo. Cells from the P. acnes-, PS- or saline-
(control group) treated mice were analyzed 24 h after treatment to
determine TLR, co-stimulatory molecule, MHC II and cytokine
expression by B-1c lymphocytes. The cells were stained with mAbs
to determine the absolute number (A to C) of B-1c lymphocytes
expressing the studied molecules and the mean fluorescence
intensity (MFI) of each marker (D to F). The absolute cell number
and MFI are the means of two independent experiments with
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similar results.* p,0.05 between the control and treated groups.
#p,0.05 between the P. acnes and PS treated groups.
(TIF)
Figure S3 Analysis of the activation status of B-1a
lymphocytes in vitro. The non-adherent cell population from
the P. acnes-, PS-, or saline- (control group) treated mice was
analyzed after 5 days in culture to determine TLR, co-stimulatory
molecule, MHC II and cytokine expression by B-1a lymphocytes.
The cells were stained with mAbs to determine the absolute
number (A to C) of B-1a lymphocytes expressing the studied
molecules and the mean fluorescence intensity (MFI) of each
marker (D to F). The absolute cell number and MFI are the means
of two independent experiments with similar results. * p,0.05
between the control and treated groups. # p,0.05 between the P.
acnes and PS treated groups.
(TIF)
Figure S4 Analysis of the activation status of B-1c
lymphocytes in vitro. The non-adherent cell population from
the P. acnes-, PS-, or saline- (control group) treated mice was
analyzed after 5 days in culture to determine TLR, co-stimulatory
molecule, MHC II and cytokine expression by B-1c lymphocytes.
The cells were stained with mAbs to determine the absolute
number (A to C) of B-1c lymphocytes expressing the studied
molecules and the mean fluorescence intensity (MFI) of each
marker (D to F). The absolute cell number and MFI are the means
of two independent experiments with similar results. * p,0.05
between the control and treated groups. # p,0.05 between the P.
acnes and PS treated groups.
(TIF)
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